Engineering STING/TLR Agonist Payloads to Amplify Anti-Tumor Immune Responses Without Triggering Cytokine Induction
Time: 9:45 am
day: Conference Day One
Details:
- Discussing the synthesis and PK profile of E7766 STING agonist payload for PSMA targeting ADC
- Analyzing in vitro and in vivo studies showing mitigation of ISAC tox concerns affiliated with cytokine induction
- Exploring the therapeutic niche and potential of STING agonist payloads
